Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glycaemic Deterioration
32%
Clinical Variables
30%
LDL Cholesterol
25%
Diabetes Progression
25%
Clinical Characteristics
23%
Hemoglobin A1c (HbA1c)
23%
Molecular Signature
23%
Systems of Care
22%
Diabetes Management
22%
C-peptide
21%
Mild Diabetes
20%
Diabetes Subgroups
18%
Scotland
18%
Diabetes Clusters
17%
Diabetes Subtypes
17%
Severe Insulin-deficient Diabetes
17%
Newly Diagnosed
16%
Rapid Progression
15%
Insulin Requirement
15%
Data-driven Clustering
13%
Etiological Heterogeneity
13%
Risky Driving
13%
Machine Learning Approach
13%
Intensive Care Medicine
13%
Type 2 Diabetes Risk
13%
Omics
13%
Lipids
13%
Follistatin
13%
Clinical Heterogeneity
13%
Multi-omics
13%
Treatment Choice
13%
K-means
13%
Clinical Complications
13%
Risk Factors
13%
Clinical Treatment
13%
Diabetes Genetics
13%
Tayside
13%
Insulin
12%
Disease Mechanisms
11%
Sphingomyelin
11%
Proteomics Data
10%
Type 2 Diabetic Patients
10%
Cluster-based
9%
Disease Progression
9%
Insulin Resistance
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Plasma Lipidomics
9%
Quality-adjusted Life Years
9%
Plasma Proteomics
9%
Medication Pattern
9%
Predictors of Progression
9%
High Risk
8%
Treatment Intensification
8%
Triacylglycerol
8%
Severe Insulin-resistant Diabetes
7%
HOMA2
7%
Personalized Treatment
7%
Homocitrulline
6%
SPOCK1
6%
Islet Cell Apoptosis
6%
DIABLO
6%
Triacylglycerol Species
6%
IL-18R
6%
RTN4R
6%
α-aminoadipic Acid
6%
CRELD1
6%
Growth Differentiation factor-15 (GDF-15)
6%
Therapeutic Avenues
6%
Nuclear factor-κB
6%
Db Mouse
6%
Molecular Classes
6%
Leucine
6%
Prognostic Utility
6%
Multidisciplinary Approach
6%
Diabetes Incidence
6%
High-fat Feeding
6%
Diabetes Prevalence
6%
Glucose Tolerance
6%
Potential Therapeutics
6%
Two-level
6%
Progression Rate
6%
Interleukin-18 (IL-18)
6%
Male Mice
6%
Replication Protein A
6%
Diabetic
5%
Scania
5%
Mild Age-related Diabetes
5%
Biochemistry, Genetics and Molecular Biology
Tamsulosin
41%
Blood Plasma
30%
C-Peptide
28%
Genetics
27%
HDL-Cholesterol
23%
Lipidomics
18%
Proteomics
18%
Lipid
18%
Insulin Resistance
16%
Metabolite
16%
Quality Adjusted Life Year
13%
Follistatin
13%
Genetic Risk
13%
Dyslipidemia
13%
Metabolomics
11%
Triglyceride
10%
Sphingomyelin
10%
Genetic Marker
9%
Triacylglycerol Level
6%
Multifactorial Disease
6%
Cytokine
6%
Tissue Metabolism
6%
Amino Acids
6%
GDF15
6%
Lifespan
6%
Prevalence
6%
Minimum Inhibitory Concentration
6%
Replication Protein
6%
Immunoglobulin Enhancer Binding Protein
6%
Db/Db Mouse
6%
Interleukin 18
6%
Diglyceride
6%
Isoleucine
6%
Malate Dehydrogenase
5%